Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Thermo Fisher Scientific | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Thermo Fisher Scientific

Acquisitions help with revenue growth

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Thermo Fisher Scientific 4Q10

4Q Revenues: $2.8 billion (-2%)

4Q Earnings: $298 million (+9%)

FY Revenues: $10.8 billion (+7%)

FY Earnings: $1.0 billion (+22%)

Comments: Analytical Technologies revenues were $1.2 billion for 4Q10 (+4%) and $4.6 billion for FY (+11%). Laboratory Products and Services were -6% for 4Q10 ($1.7 billion) and +4% for FY ($6.7 billion). Acquisitions accounted for 3% of FY revenue growth and 2% of 4Q10 revenue growth. The company predicts revenue growth of 5-6% in 2011, not including sales generated by the Dionex acquisition, which has not yet closed.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters